Newman told CNBC that Aetna's momentum — which he described as "the tailwinds we're seeing" — accounts for the bulk of the raised revenue target, even as the company keeps a careful eye on persistently high medical costs for the remainder of the year. With the results, CVS extended its run of topping Street expectations to five straight quarters, according to Reuters. A CEO change had come in 2024, a year when the company repeatedly fell short of Wall Street expectations. Revenue from the health services se ...